JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
05/11/25 - 17:46
Diasorin’s Board of Directors approves results for the first 9 months of 2025. FY 2025 Guidance revised (255.77 KB)
31/07/25 - 16:22
Revenue Growth and Margin Expansion in H1 2025. FY 2025 Guidance Confirmed (238.17 KB)
06/05/25 - 17:41
Revenue growing +8% and EBITDA margin at 34%: Q1 Results confirm FY 2025 Guidance (268.56 KB)
14/03/25 - 16:29
The Board of Directors of Diasorin SpA approves FY2024 Results with revenues and net profit in expansion compared to Previous Year; Proposed Ordinary Dividend of € 1.20 per share (239.79 KB)
11/11/15 - 1:00
The Board of Directors approves the results for Q3'15 (778.06 KB)
30/07/15 - 2:00
H1'15 Results (777.06 KB)
12/05/15 - 2:00
The Board of Directors approves the results for Q1'15 (553.96 KB)
22/04/15 - 2:00
The Board of Directors approves the 2015-2017 plan that will be presented at the Investor Day (141.85 KB)
22/04/15 - 2:00
Shareholders' meeting approves FY Results 2014 (105.93 KB)
10/04/15 - 2:00
Investor Day-save the date (107.93 KB)
03/03/15 - 1:00